ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

35,035Medicare Part D Prescriptions Filled, Including Refills

Rank: 41 out of 3647

$601K Total Retail Price of All Prescriptions

Rank: 777 out of 3647

1,075 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 1,075 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 34,755 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$17 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,712 1,708 1 3
SIMVASTATIN 1,412 1,411 2 1
LISINOPRIL 1,227 1,223 3 4
AMLODIPINE BESYLATE 1,022 1,022 4 2
METFORMIN HCL 984 955 5 6
LOSARTAN POTASSIUM 818 808 6 11
HYDROCHLOROTHIAZIDE 810 810 7 9
RENAL CAPS 795 794 8 119
SYNTHROID 720 713 9 42
FUROSEMIDE 652 646 10 8
GLIPIZIDE 637 637 11 41
METOPROLOL SUCCINATE 633 628 12 18
METOPROLOL TARTRATE 616 615 13 7
ATORVASTATIN CALCIUM 593 587 14 13
TAMSULOSIN HCL 589 588 15 28
ATENOLOL 583 573 16 10
ALENDRONATE SODIUM 573 573 17 23
LORATADINE 567 567 18 109
TEMAZEPAM 554 554 19 47
LOVASTATIN 553 553 20 21
RANITIDINE HCL 548 548 21 29
VITAL-D RX 543 543 10 22 197
GABAPENTIN 494 487 23 17
FINASTERIDE 458 458 24 66
ALPRAZOLAM 423 422 25 31
PAROXETINE HCL 422 421 26 60
WARFARIN SODIUM 384 384 27 15
LANSOPRAZOLE 380 360 28 116
ZOLPIDEM TARTRATE 360 357 29 14
VIAGRA 359 359 30 69
ENALAPRIL MALEATE 352 352 31 35
PANTOPRAZOLE SODIUM 336 336 32 38
CARVEDILOL 323 323 33 20
PRAVASTATIN SODIUM 315 310 34 16
VITAMIN D2 282 279 35 100
DONEPEZIL HCL 266 266 36 30
FLUTICASONE PROPIONATE 265 256 37 32
CLOPIDOGREL 258 253 38 26
KLOR-CON 10 249 249 39 106
DOXAZOSIN MESYLATE 244 244 40 57
IBUPROFEN 230 225 41 55
LISINOPRIL-HYDROCHLOROTHIAZIDE 225 225 42 36
ISOSORBIDE MONONITRATE ER 221 221 43 56
GLIPIZIDE-METFORMIN 214 214 10 44 379
LOSARTAN-HYDROCHLOROTHIAZIDE 210 210 45 48
LEVOXYL 185 184 46 125
PRILOSEC OTC 184 184 10 47 285
PLAVIX 183 178 48 39
LANOXIN 182 182 49 231
SURE COMFORT 174 174 50 161
FOLIC ACID 167 166 51 95
BENICAR 167 167 51 114
SERTRALINE HCL 165 165 53 27
AMMONIUM LACTATE 161 161 54 141
GALANTAMINE HBR 158 158 55 245
LORAZEPAM 147 147 56 73
NAMENDA 142 142 57 49
LANTUS 140 139 58 59
CLOTRIMAZOLE-BETAMETHASONE 136 136 59 84
VENTOLIN HFA 134 133 60 88
LACTULOSE 131 130 61 128
ALLOPURINOL 129 129 62 37
HYDROCODONE-ACETAMINOPHEN 128 120 S3 63 12
CLONIDINE HCL 128 128 63 46
TRAZODONE HCL 126 125 65 64
CLONAZEPAM 123 121 66 146
CLOBETASOL PROPIONATE 122 122 67 188
DICYCLOMINE HCL 119 119 68 194
SYMBICORT 116 113 69 153
AFEDITAB CR 116 116 69 237
VERAPAMIL ER 116 116 69 99
CILOSTAZOL 112 112 72 168
HUMULIN 70-30 111 111 73 192
NAPROXEN 102 102 74 70
CITALOPRAM HBR 100 100 75 25
GEMFIBROZIL 100 100 75 82
KETOCONAZOLE 97 94 77 132
DILTIAZEM 24HR ER 97 96 77 164
CLORAZEPATE DIPOTASSIUM 97 97 77 200
ACETAMINOPHEN-CODEINE 96 96 S3 80 149
CETIRIZINE HCL 94 94 81 213
PREDNISONE 93 92 82 43
QVAR 93 89 82 294
GLIPIZIDE XL 92 92 84 190
HYDRALAZINE HCL 91 91 85 81
FAMOTIDINE 90 90 86 61
NYSTATIN-TRIAMCINOLONE 90 90 86 201
NIFEDIPINE ER 87 86 88 67
DETROL LA 85 85 89 292
ADVAIR DISKUS 83 83 90 52
FLUNISOLIDE 83 83 90 284
PROPRANOLOL HCL 82 82 92 156
TRIAMTERENE-HCTZ 81 81 93 58
GLYBURIDE-METFORMIN HCL 80 80 R 94 94
PROCTOZONE-HC 80 80 94 216
TRAMADOL HCL-ACETAMINOPHEN 80 79 94 152
MECLIZINE HCL 71 71 97 85
OXYBUTYNIN CHLORIDE ER 68 68 98 169
BENICAR HCT 66 65 99 165
SULFAMETHOXAZOLE-TRIMETHOPRIM 66 62 99 110
LANTUS SOLOSTAR 64 64 101 124
CIPROFLOXACIN HCL 63 62 102 53
SINGULAIR 62 54 103 90
FENOFIBRATE 61 61 104 50
ACTOS 59 59 105 148
TRIAMCINOLONE ACETONIDE 59 58 105 136
MELOXICAM 58 58 107 33
FOLBIC 58 58 107 255
TRAMADOL HCL 57 57 109 22
ASMANEX 56 56 110 579
DICLOFENAC SODIUM 56 55 110 86
NYSTOP 55 55 112 323
GLYBURIDE 53 52 R 113 54
AMLODIPINE BESYLATE-BENAZEPRIL 52 52 114 74
CARBIDOPA-LEVODOPA 52 52 114 127
RISPERIDONE 51 42 116 83
FELODIPINE ER 50 50 117 186
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.